Skip to main content

Table 3 Treatments and outcomes of 168 hospitalized children with severe Adv. pneumonia

From: Impact of extracorporeal membrane oxygenation in immunocompetent children with severe adenovirus pneumonia

Characteristics

Total

non-ECMO group

ECMO group

P-value

N = 168

(n, %)

(x ± s)

N = 149

(n, %)

(x ± s)

N = 19

(n, %)

(x ± s)

Treatments (n)

    

Antibiotics

145 (97.32%)

126 (84.53%)

19 (100.00%)

0.65

Immunoglobulin

162 (96.43%)

145 (97.32%)

17 (89.47%)

0.08

Corticosteroid

109 (64.88%)

96 (64.43%)

13 (68.42%)

0.69

Mechanical ventilation (n)

    

Conventional Mechanical ventilation

41 (24.40%)

22 (14.77%)

19 (100.00%)

0.00

High-frequency Oscillatory Ventilation

19 (11.31%)

4 (2.68%)

15 (78.95%)

0.00

FiO2 > 60%

37 (22.02%)

18 (12.08%)

19 (100.00%)

0.00

PIP > 30cmH2O

27 (16.07%)

15 (10.07%)

12 (63.16%)

0.00

PEEP > 8cmH2O

27 (16.07%)

10 (6.71%)

16 (84.21%)

0.00

CRRT

15 (8.93%)

3 (2.01%)

12 (63.16%)

0.00

Complication

    

Respiratory failure

47 (27.98%)

28 (18.79%)

19 (100.00%)

0.00

ARDS

18 (10.71%)

3 (2.01%)

15 (78.95%)

0.00

Septic shock

18 (10.71%)

4 (2.68%)

14 (73.68%)

0.00

Acute renal failure

4 (2.38%)

0 (0.00%)

4 (21.05%)

0.00

Pneumorrhagia

3 (1.79%)

1 (0.67%)

2 (10.53%)

0.00

Gastrointestinal hemorrhage

3 (1.79%)

2 (1.19%)

1 (5.26%)

0.22

Heart failure

2 (1.19%)

0 (0.00%)

2 (10.53%)

0.00

Liver failure

2 (1.19%)

0 (0.00%)

2 (10.53%)

0.00

Outcomes

    

The length of hospitalization (days)

18.12 ± 13.08

15.82 ± 8.31

37.13 ± 25.31

0.00

Dead (n)

13 (7.74%)

6 (3.57%)

7 (36.84%)

0.00

  1. P < 0.05 are shown in bold